Items 61 ~ 70 of 5370, Page 7 of 537 
  06/18/2019 MERCK - Business
LYNPARZA® (olaparib) Approved in the EU for Use as First-Line Maintenance Therapy in Patients With BRCA-Mutated Advanced Ovarian Cancer
- AstraZeneca and Merck’s LYNPARZA Reduced the Risk of Disease Progression or Death by 70% Compared to Placebo Following Response to Platinum-Based Chemotherapy in Phase 3 SOLO-1 Trial / LYNPARZA is the Only PARP Inhibitor Approved in the EU for This Indication
  06/17/2019 Abbott - Business
Abbott Launches First-ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes
- Afinion™ HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation / Assay is the first and only rapid point-of-care test cleared by the U.S. Food and Drug Administration (FDA) to aid healthcare professionals in the diagnosis of diabetes
  06/14/2019 American Cancer Society - Clinical
FDA Approves Keytruda (Pembrolizumab) for Head and Neck Cancer
- The US Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) as a first-line treatment for people with advanced head and neck cancer.
  06/13/2019 MERCK - Business
IBM, KPMG, Merck and Walmart to collaborate as part of FDA’s program to evaluate the use of blockchain to protect pharmaceutical product integrity
- The FDA pilot program explores innovative and emerging approaches for the tracing and verification of prescription products
  06/13/2019 American Medical Association (AMA) - Public Health
AMA policy advocates to eliminate non-medical vaccine exemptions
- The AMA adopted policy to actively advocate for legistration, and policies thah incentivize states to eliminte non-medical exemptions from immunizations.
  06/13/2019 WHO - Health and Science
New study finds no link between HIV infection and contraceptive methods
  06/13/2019 American Cancer Society - Health and Science
All Black Women in the United States May Not Have the Same Level of Risk for Triple-Negative Breast Cancer
- We've known for a while that triple-negative breast cancer is more common in black women in the United States, compared to other groups. The news is the prevalence varies significantly depending on where these women were born. American Cancer Society (ACS) researchers found that among black women, those born in the US and Western Africa were diagnosed more often with triple-negative breast cancer than women born in East Africa. The authors published their findings in Cancer, an ACS peer-reviewed journal.
  06/13/2019 Radiological Society of North America - Clinical
MRI Plays A Role in Diagnosis of Cocaine-related Damage to the Heart
- Cardiac MRI can detect cocaine's effects on the cardiovascular system and help differentiate between acute and chronic conditions. / Cocaine abuse can have devastating effects on the heart.
  06/12/2019 American Cancer Society - Clinical
FDA Approves Polivy (Polatuzumab Vedotin-piiq) for Lymphoma
- The US Food and Drug Administration (FDA) has approved the antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) to treat people with diffuse large B-cell lymphoma (DLBCL).
  06/11/2019 American Cancer Society - Health and Science
Population of US Cancer Survivors Grows to Nearly 17 Million
- A new report by the American Cancer Society ? in collaboration with the National Cancer Institute ? estimates there are more than 16.9 million cancer survivors alive in the US today, and that number will grow to more than 22.1 million by 2030.

<<  <  [1]  [2]  [3]  [4]  [5]  [6]  [7[8]  [9]  [10]  >  >>
more